Please login to the form below

Not currently logged in

FDA approves Mirena for IUD users

The US FDA has approved Mirena to treat heavy menstrual bleeding in women who use intra-uterine contraception

The US Food and Drink Administration (FDA) has approved Mirena to treat heavy menstrual bleeding in women who use intra-uterine contraception.

Mirena (levonorgestrel intra-uterine system), by Bayer HealthCare, was approved as a contraceptive by the FDA in 2000 and is the first intra-uterine device to be approved by the FDA for this additional indication.

"In the primary clinical trial, women using Mirena showed a statistically significant reduction in menstrual blood loss," said Dr Scott Monroe, director of the Division of Reproductive and Urologic Products in the FDA's Center for Drug Evaluation and Research.

Participants in the clinical trial had excessive menstrual blood loss prior to treatment and did not have any medical conditions that are known to cause heavy menstrual bleeding, except for small uterine fibroids in some of the women.

Clinical studies to support both the contraception and heavy menstrual bleeding indications have excluded women who have never been pregnant.

5th October 2009


Featured jobs

Subscribe to our email news alerts


Add my company Conferences, Events and Exhibition Stands is one of the UK’s leading event and exhibition agencies, specialising in healthcare. We understand your communication goals, whether...

Latest intelligence

Unlocking the potential of science and technology in the UK
Greater collaboration is vital in post-Brexit UK, says Alderley Park leader...
NHS regional footprints
What to expect from 2019...
Not another weight-loss ad
Christmas is over and the gyms are packed, it’s a never-ending tale. But why do we do it to ourselves every year?...